Two Sigma Investments’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Buy |
443,521
+275,172
| +163% | +$867K | ﹤0.01% | 2010 |
|
|
2025
Q1 | $529K | Buy |
168,349
+63,122
| +60% | +$198K | ﹤0.01% | 2443 |
|
|
2024
Q4 | $457K | Sell |
105,227
-79,346
| -43% | -$344K | ﹤0.01% | 2513 |
|
|
2024
Q3 | $493K | Sell |
184,573
-34,056
| -16% | -$90.9K | ﹤0.01% | 2422 |
|
|
2024
Q2 | $485K | Buy |
218,629
+195,662
| +852% | +$434K | ﹤0.01% | 2313 |
|
|
2024
Q1 | $123K | Sell |
22,967
-7,700
| -25% | -$41.1K | ﹤0.01% | 2730 |
|
|
2023
Q4 | $45.4K | Sell |
30,667
-22,600
| -42% | -$33.4K | ﹤0.01% | 2915 |
|
|
2023
Q3 | $74K | Sell |
53,267
-39,965
| -43% | -$55.6K | ﹤0.01% | 2697 |
|
|
2023
Q2 | $137K | Buy |
93,232
+63,232
| +211% | +$93K | ﹤0.01% | 2631 |
|
|
2023
Q1 | $49.5K | Buy |
30,000
+6,691
| +29% | +$11K | ﹤0.01% | 2681 |
|
|
2022
Q4 | $32.6K | Buy |
+23,309
| New | +$32.6K | ﹤0.01% | 2581 |
|
|
2022
Q3 | – | Sell |
-12,019
| Closed | -$26K | – | 2474 |
|
|
2022
Q2 | $26K | Sell |
12,019
-454,328
| -97% | -$983K | ﹤0.01% | 2319 |
|
|
2022
Q1 | $1.16M | Buy |
466,347
+88,978
| +24% | +$221K | ﹤0.01% | 1612 |
|
|
2021
Q4 | $2.27M | Sell |
377,369
-227,381
| -38% | -$1.37M | ﹤0.01% | 1272 |
|
|
2021
Q3 | $4.03M | Sell |
604,750
-103,918
| -15% | -$692K | 0.01% | 1014 |
|
|
2021
Q2 | $4.71M | Sell |
708,668
-16,291
| -2% | -$108K | 0.01% | 949 |
|
|
2021
Q1 | $6.71M | Buy |
724,959
+385,277
| +113% | +$3.57M | 0.02% | 724 |
|
|
2020
Q4 | $6.11M | Buy |
+339,682
| New | +$6.11M | 0.02% | 660 |
|
|
2018
Q4 | – | Sell |
-6,198
| Closed | -$30K | – | 2140 |
|
|
2018
Q3 | $30K | Buy |
+6,198
| New | +$30K | ﹤0.01% | 1950 |
|
|
2015
Q3 | – | Sell |
-740
| Closed | -$541K | – | 1711 |
|
|
2015
Q2 | $541K | Buy |
+740
| New | +$541K | ﹤0.01% | 1683 |
|